BASF logo

BASF

Last updated January 31, 2026
319
Innovation Areas
13,244
Inventors
154
Collaborations

Engineered microbial promoter sequences: BASFRecent Research Landscape

Uncontrolled extracellular matrix formation and weak promoter activity limit protein secretion yields in microbial hosts. These modifications engineer the transcriptional control and regulatory pathways to maximize compound production efficiency.

What technical problems is BASF addressing in Engineered microbial promoter sequences?

Inflexible gene expression levels

(9)evidences

Low transcriptional activity and poor metabolic control limit the production of target compounds in microbial hosts. Increasing expression efficiency overcomes bottlenecks in industrial fermentation.

Metabolic byproduct toxicity

(4)evidences

Firmicutes and related industrial strains often exhibit poor DNA uptake and conjugation competence. Overcoming this barrier allows for more efficient genetic engineering and metabolic pathway optimization.

Low protein recovery yield

(4)evidences

Inefficient separation of proteins from complex fermentation mixtures leads to significant product loss. Improving recovery efficiency increases the economic viability of large-scale microbial manufacturing.